Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 20, 2014, Pages 7254-7259

  Viola Villegas, Nerissa Therese ^a,b   Carlin, Sean D ^a,b   Ackerstaff, Ellen ^c   Sevak, Kuntal K ^b   Divilov, Vadim ^b   Serganova, Inna ^d   Kruchevsky, Natalia ^c   Anderson, Michael ^e   Blasberg, Ronald G ^a,b,d   Andreev, Oleg A ^e   Engelman, Donald M ^f   Koutcher, Jason A ^a,b,c,g   Reshetnyak, Yana K ^e   Lewis, Jason S ^a,b  

^a Molecular Pharmacology and Chemistry Program   (United States)

^b Departments of Psychiatry   (United States)

^c Departments of Medical Physics   (United States)

^d Departments of Neurology Medicine   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF RHODE ISLAND   (United States)

^g YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID VAR7 CU 64; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID VAR7 GA 68; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID WT CU 64; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID WT GA 68; CARBONATE DEHYDRATASE IX; COPPER 64; GALLIUM 68; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; PH LOW INSERTION PEPTIDE CU 64; PH LOW INSERTION PEPTIDE GA 68; TETRAXETAN; TRACER; UNCLASSIFIED DRUG;

ACIDIFICATION; ACIDITY; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL VIABILITY; CONTROLLED STUDY; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG RETENTION; DRUG SOLUBILITY; IN VITRO STUDY; ISOTOPE LABELING; LNCAP CELL LINE; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TUMOR VASCULARIZATION;

EID: 84901036369     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Gottfried E, Kreutz M, Mackensen A (2012) Tumor metabolism as modulator of immune response and tumor progression. Semin Cancer Biol 22(4):335-341.
2. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324(5930):1029-1033.
3. Chiche J, Brahimi-Horn MC, Pouysségur J (2010) Tumour hypoxia induces a metabolic shift causing acidosis: A common feature in cancer. J Cell Mol Med 14(4):771-794.
4. Guillaumond F, et al. (2013) Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci USA 110(10):3919-3924.
5. Park HJ, Lyons JC, Ohtsubo T, Song CW (1999) Acidic environment causes apoptosis by increasing caspase activity. Br J Cancer 80(12):1892-1897.
6. Williams AC, Collard TJ, Paraskeva C (1999) An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: Implications for clonal selection during colorectal carcinogenesis. Oncogene 18(21): 3199-3204.
7. Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10(10):767-777.
8. Zhang X, Lin Y, Gillies RJ (2010) Tumor pH and its measurement. J Nucl Med 51(8): 1167-1170.
9. Mazzio EA, Boukli N, Rivera N, Soliman KF (2012) Pericellular pH homeostasis is a primary function of the Warburg effect: Inversion of metabolic systems to control lactate steady state in tumor cells. Cancer Sci 103(3):422-432.
10. de Groof AJ, et al. (2009) Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer 8:54.
11. Wu M, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292(1):C125-C136.
12. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891-899.
13. Carmeliet P, et al. (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394(6692):485-490.
14. Jang A, Hill RP (1997) An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-Associated genes in murine tumor cells. Clin Exp Metastasis 15(5):469-483.
15. Estrella V, et al. (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73(5):1524-1535.
16. An M, Wijesinghe D, Andreev OA, Reshetnyak YK, Engelman DM (2010) pH-(low)- insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. Proc Natl Acad Sci USA 107(47):20246-20250.
17. Moshnikova A, Moshnikova V, Andreev OA, Reshetnyak YK (2013) Antiproliferative effect of pHLIP-Amanitin. Biochemistry 52(7):1171-1178.
18. Daumar P, et al. (2012) Efficient (18)F-labeling of large 37-Amino-Acid pHLIP peptide analogues and their biological evaluation. Bioconjug Chem 23(8):1557-1566.
19. Andreev OA, et al. (2010) pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proc Natl Acad Sci USA 107(9): 4081-4086.
20. Vavere AL, et al. (2009) A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res 69(10):4510-4516.
21. Weerakkody D, et al. (2013) Family of pH (low) insertion peptides for tumor targeting. Proc Natl Acad Sci USA 110(15):5834-5839.
22. Antunes P, et al. (2007) Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging 34(7):982-993.
23. Wadas TJ, Wong EH, Weisman GR, Anderson CJ (2010) Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev 110(5):2858-2902.
24. Andreev OA, et al. (2007) Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci USA 104(19):7893-7898.
25. Bass LA, Wang M, Welch MJ, Anderson CJ (2000) In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjug Chem 11(4): 527-532.
26. Feng B, LaPerle JL, Chang G, Varma MV (2010) Renal clearance in drug discovery and development: Molecular descriptors, drug transporters and disease state. Expert Opin Drug Metab Toxicol 6(8):939-952.
27. Ait-Mohand S, et al. (2011) Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates. Bioconjug Chem 22(8):1729-1735.
28. De Silva RA, et al. (2012) Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development. Nucl Med Biol 39(8): 1099-1104.
29. Fischer PM (2003) The design, synthesis and application of stereochemical and directional peptide isomers: A critical review. Curr Protein Pept Sci 4(5):339-356.
30. Riviere I, Brose K, Mulligan RC (1995) Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92(15):6733-6737.
31. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA (2004) pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag 23(5):57-64.
32. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM (2002) MRI of the tumor microenvironment. J Magn Reson Imaging 16(4):430-450.
33. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49(23): 6449-6465.
34. Raghunand N, et al. (1999) Plasmalemmal pH-gradients in drug-sensitive and drugresistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem Pharmacol 57(3):309-312.
35. Raghunand N (2006) Tissue pH measurement by magnetic resonance spectroscopy and imaging. Methods Mol Med 124:347-364.
36. Tannock IF, Rotin D (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49(16):4373-4384.
37. Paradise RK, Whitfield MJ, Lauffenburger DA, Van Vliet KJ (2013) Directional cell migration in an extracellular pH gradient: A model study with an engineered cell line and primary microvascular endothelial cells. Exp Cell Res 319(4):487-497.
38. Helmlinger G, Yuan F, Dellian M, Jain RK (1997) Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat Med 3(2):177-182.
39. Molavian HR, Kohandel M, Milosevic M, Sivaloganathan S (2011) Deriving mechanisms responsible for the lack of correlation between hypoxia and acidity in solid tumors. PLoS ONE 6(12):e28101.
40. Chen JL, et al. (2008) The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet 4(12):e1000293.
41. Arteel GE, Thurman RG, Yates JM, Raleigh JA (1995) Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72(4):889-895.
42. Kleiter MM, et al. (2006) A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int J Radiat Oncol Biol Phys 64(2):592-602.
43. Russell J, et al. (2009) Immunohistochemical detection of changes in tumor hypoxia. Int J Radiat Oncol Biol Phys 73(4):1177-1186.
44. Serganova I, et al. (2004) Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice. Cancer Res 64(17):6101-6108.
45. Soto GE, Zhu Z, Evelhoch JL, Ackerman JJ (1996) Tumor 31P NMR pH measurements in vivo: A comparison of inorganic phosphate and intracellular 2-deoxyglucose-6-phosphate as pHnmr indicators in murine radiation-induced fibrosarcoma-1. Magn Reson Med 36(5):698-704.